Charity BreakdownCanadian charity filings, itemized

Israel Cancer Research Fund (toronto)

Public foundation · Concord, Ontario · BN 816102347RR0001 · Foundations · website

Your $100, itemizedIsrael Cancer Research Fund (toronto)Fiscal year ended June 30, 2024
Gifts to other charities$60
Fundraising$23
Management & admin$17
TOTAL$100
Registered

Source: T3010 return, FPE 2024-06-30. Split of total expenditures ($2,803,401) as filed with the CRA.

Israel Cancer Research Fund (toronto) is a public foundation based in Concord, Ontario, classified by the CRA under foundations. In its fiscal year ending June 30, 2024, it reported $2.4M in revenue and $2.8M in expenditures. Spending exceeded revenue that year — the gap came out of reserves.

Its funding that year was roughly 56% from donations, 26% from other charities. In 2024, 45 other registered charities reported granting it a combined $529K.

Compared with 1,554 grantmaking charities of similar size, its share of spending on mission — charitable programs plus grants to other charities — ranked above 13% of peers. Its fundraising cost per donated dollar was higher than 75% of that peer group. Its highest-paid position fell in the $160,000–199,999 range. The charity reported 3 permanent full-time positions.

Revenue has grown substantially over its filings on record here, from $1.5M in 2020 to $2.4M in 2024. Its filed list of directors and trustees shows 25 names.

In its own words

The israel cancer research fund (toronto) provides funds to aid in the research of cancer in all phases: causes detection diagnosis treatment cure and care.

Ongoing-program description from its T3010 filing, verbatim.

The ledger, 20202024

YearRevenueSpendingProgramsFundraisingGifts outNet assets
2024$2.4M$2.8M$642K$1.7M$3.4M
2023$2.8M$2.4M$519K$1.4M$3.8M
2022$1.8M$3.2M$171K$1.4M$3.4M
2021$3.1M$1.7M$111K$977K$3.5M
2020$1.5M$1.9M$301K$1.2M$2.1M

Revenue printed in red where the year ran a deficit. Fiscal years by period end.

Money between charities, 2024

As reported on the donors’ own T3010 qualified-donee schedules.

What it pays

Its ten highest-paid positions, by band:

  • $160,000–199,9991 position
  • $40,000–79,9992 positions
  • Permanent full-time positions3
  • Total compensation, all staff$337K

Schedule 3 of its 2024 return. The CRA discloses bands, not names or exact salaries.

Directors & trustees (2024)

Stephen Altbaum (treasurer); Tammy Anklewicz (board member); Jeff Bly (executive member); Rena Buckstein (board member); Vera Finkelstein (board member); Bonnie Fish (immediate past president); Richard Flomen (board member); Bryna Goldberg (international chair); Greg Joffe (board member); Ian Kady (board member); Rick Kuwayti (board member); David Malkin (board member); Fern Reich (board member); Matthew Sapera (board member); Faith Sherman (board member); Norman Shiner (board member); Alexandra Silverberg (board member); Gillian Tessis (executive member); Dov Zevy (executive member); Jade Zylberberg (board member); Neil Berinstein (board member); Suzy Kauffman (board member); Laurier Sheff (board member); Areila Gutfrajnd (board member); Alison Himel (board president).

As listed on its 2024 return.

Check the source

Every figure on this page is from Israel Cancer Research Fund (toronto)’s own T3010 filings, published by the Canada Revenue Agency. Verify against the CRA’s charities listing (search BN 816102347RR0001), or read how we compute the receipt.